051: Ada Le and Mousumi Sannigrahi on behavioural science in healthcare
Seri yang sudah diarsipkan ("Feed tidak aktif" status)
When? This feed was archived on February 15, 2025 07:07 (). Last successful fetch was on December 27, 2024 11:08 ()
Why? Feed tidak aktif status. Server kami tidak mendapatkan feed podcast yang valid secara terus-menerus.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 404797533 series 3556050
This week we’re diving into healthcare; what could be more critical? To help me understand how behavioural science is impacting this field, I’m joined by Dr. Ada Le, healthcare expert at BEworks and Dr. Mousumi Sannigrahi, newly installed as Head of Commercial for Innovative Medicines at Fosun Pharma US, having spent the last 8 years at Novartis Pharma.
Show notes
- What’s happening at the intersection of behavioural science and the pharma industry?
- How behavioural science plays out at Fosun vs. Novartis
- The next frontier for healthcare and behavioural science
- What needs to happen to move to a more human-centric approach to healthcare?
- The goal of the 1% Steps for Health Care Reform Project
- What are easy wins that the pharma industry can enact now?
- Psychological barriers for patients with autoimmune disease
- Rosy retrospection bias and failure to prescribe the right treatment
- David Robson and expectation effects: how mindset can alter our lives
- Dan Ariely’s end of life theories and research
- The scientific method of problem solving vs. more subtle placebo effects
- Hopes for healthcare in the next year
Please leave a review if you like the podcast; and share with friends. Your support makes us very happy!
85 episode